![David Gordon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
David Gordon served as the Chief Medical Officer at Aclaris Therapeutics, Inc. from 2018 to 2022.
Prior to that, he was the SVP and Head of Dermatology Research & Development at GSK Plc from 2016 to 2018.
Dr. Gordon earned a doctorate degree from the University of Aberdeen.
Eerdere bekende functies van David Gordon
| Bedrijven | Functie | Einde |
|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 07-01-2022 |
| GSK PLC | Hoofd Techniek/Wetenschap/O&O | 01-03-2018 |
Opleiding van David Gordon
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
84
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Aclaris Therapeutics, Inc.
 Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Aberdeen
 University of Aberdeen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
